These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6225570)

  • 21. Circulating T cell subsets in euthyroid Graves' disease.
    Bagnasco M; Canonica GW; Ferrini S; Ciprandi G; Dirienzo W; Giordano G; Ferrini O
    J Endocrinol Invest; 1983 Apr; 6(2):119-23. PubMed ID: 6223066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune thyroid disease--a perspective.
    Volpé R
    Mol Biol Med; 1986 Feb; 3(1):25-51. PubMed ID: 2870410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of the effect of suppressor T lymphocytes on the induction of antithyroid microsomal antibody-secreting cells in autoimmune thyroid disease.
    Iitaka M; Aguayo JF; Iwatani Y; Row VV; Volpé R
    J Clin Endocrinol Metab; 1988 Apr; 66(4):708-14. PubMed ID: 2964455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
    Hopf U; Fiek T; Grün R; Zuschneid W
    J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of anti-thyroid plasma membrane antibody in patients with various thyroid diseases by solid phase enzyme-immunoassay].
    Iitaka M
    Nihon Naibunpi Gakkai Zasshi; 1984 Jul; 60(7):881-91. PubMed ID: 6389194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathogenesis of Graves' disease and Hashimoto's thyroiditis.
    Volpé R; Farid NR; Von Westarp C; Row VV
    Clin Endocrinol (Oxf); 1974 Jul; 3(3):239-61. PubMed ID: 4601273
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.
    Hidaka Y; Okumura M; Shimaoka Y; Takeoka K; Tada H; Amino N
    Thyroid; 1998 Mar; 8(3):235-9. PubMed ID: 9545110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistological phenotyping of thyroid infiltrating lymphocytes in Graves' disease and Hashimoto's thyroiditis.
    Misaki T; Konishi J; Nakashima T; Iida Y; Kasagi K; Endo K; Uchiyama T; Kuma K; Torizuka K
    Clin Exp Immunol; 1985 Apr; 60(1):104-10. PubMed ID: 3891164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
    Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
    J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell sensitization to autologous thyroid cells and normal non-specific suppressor T-cell function in Graves' disease.
    Davies TF; Bermas B; Platzer M; Roman SH
    Clin Endocrinol (Oxf); 1985 Feb; 22(2):155-67. PubMed ID: 3157510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressor T-lymphocyte deficiency in Graves' disease and Hashimoto's thyroiditis.
    Okita N; Row VV; Volpe R
    J Clin Endocrinol Metab; 1981 Mar; 52(3):528-33. PubMed ID: 6450775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
    Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y
    Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of immunogenic regions in TSH receptor for Graves' IgG and Hashimoto's IgG].
    Murakami M; Miyashita K; Mori M
    Nihon Rinsho; 1994 Apr; 52(4):1057-62. PubMed ID: 8196164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
    Selenkow HA; Wyman P; Allweiss P
    Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for thyroid antigen-reactive T lymphocytes infiltrating the thyroid gland in Graves' disease.
    Tötterman TH; Andersson LC; Häyry P
    Clin Endocrinol (Oxf); 1979 Jul; 11(1):59-68. PubMed ID: 391444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathyroidal T cell clones from patients with autoimmune thyroid disease.
    MacKenzie WA; Schwartz AE; Friedman EW; Davies TF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):818-24. PubMed ID: 2880865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological activity of lymphocytotoxic antibodies in Graves' disease and Hashimoto's thyroiditis.
    Pruzanski W; Capes H; Baur R; Wenzel BE; Row VV; Volpé R
    J Endocrinol Invest; 1984 Feb; 7(1):7-13. PubMed ID: 6609185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients.
    Ohashi H; Okugawa T; Itoh M
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):502-9. PubMed ID: 1684685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy.
    Tandon N; Yan SL; Arnold K; Metcalfe RA; Weetman AP
    Clin Endocrinol (Oxf); 1994 May; 40(5):629-39. PubMed ID: 8013144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.